Hepatitis C Treatment Experiences and Decision Making Among Patients Living With HIV Infection

Journal of the Association of Nurses in AIDS Care

Volumn 21, Issue 1, 2010, Pages 63-74

  Bova, Carol ^a   Ogawa, Lisa Fink ^a   Sullivan Bolyai, Susan ^a  

^a NONE

Author keywords

decision making; hepatitis C; HIV

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; COMORBIDITY; DECISION MAKING; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED;

ADULT; ANTIVIRAL AGENTS; COMORBIDITY; DECISION MAKING; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 72149130029     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2009.07.009     Document Type: Article

References (42)

1. Alberti A., Clumeck N., Collins S., Gerlich W., Lundgren J., Palu G., et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. Journal of Hepatology 42 (2005) 615-624
2. Alter M.J. Epidemiology of Hepatitis C. Hepatology 26 Suppl. (1997) 62S-65S
3. Bandura A. Social foundations of thought and action: A social cognitive theory (1986), Prentice-Hall, Englewood Cliffs, NJ
4. Benhamou Y., Bochet M., DiMartino V., Charlotte F., Azria F., Coutellier A., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30 (1999) 1054-1058
5. Bica I., McGovern B., Dhar R., Stone D., McGowan K., Scheib R., et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases 32 (2001) 492-497
6. Bova C., Jaffarian C., Himlan P., Mangini L., and Ogawa L. The symptom experience of HIV/hepatitis C virus-coinfected adults. Journal of the Association of Nurses in AIDS Care 19 (2008) 170-180
7. Carrat F., Bani-Sadr F., Pol S., Rosenthal E., Lunel-Fabiani F., Benzekri A., et al. Pegylated interferon alfa-2b vs. standard interferon alfa-2b plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. Journal of the American Medical Association 292 (2004) 2839-2848
8. Centers for Disease Control and Prevention. The 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41 RR-17 (1992)
9. Chung R., Andersen J., Volberding P.A., Robbins G.K., Liu T., Sherman K.E., et al. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. New England Journal of Medicine 351 (2004) 451-459
10. Dieterich D.T. Hepatitis C infection in HIV. AIDS Patient Care and STDS 18 (2004) 127-130
11. Glaser B.G., and Strauss A.L. The discovery of grounded theory: Strategies for qualitative research (1967), Aldine, Chicago
12. Grow J.M., and Christopher S.A. Breaking the silence surrounding Hepatitis C by promoting self-efficacy: Hepatitis C public service announcements. Qualitative Health Research 18 (2008) 1401-1412
13. Highleyman L. Focus on hepatitis. Final APRICOT, ACTG A5071 results. International Association of Physicians in AIDS Care Monthly 10 (2004) 356-357
14. Khokhar O.S., and Lewis J.H. Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: Do they alter their decision with time?. Digestive Disease Science 52 (2006) 1168-1176
15. Lazarus R.S., and Folkman S. Stress, appraisal and coping (1984), Springer, New York
16. Lincoln Y.S., and Guba E.G. Naturalistic inquiry (1985), Sage, Thousand Oaks, CA
17. Lo Re V., Kostman J.R., and Amorosa V.K. Management of complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clinics in Liver Disease 12 (2008) 587-609
18. McNally S., Temple-Smith M., Sievert W., and Pitts M.K. Now, later or never? Challenges associated with hepatitis C treatment. Australian and New Zealand Journal of Public Health 30 (2006) 422-427
19. Mehta S.H., Lucas G.M., Mirel L.B., Torbenson M., Higgins Y., Moore R.D., et al. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 20 (2006) 2361-2369
20. Mehta S.H., Genberg B.L., Astemborski J., Kavasery R., Kirk G., Vlahov D., et al. Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health 33 (2008) 126-133
21. Mehta S.H., Thomas D.L., Sulkowski M., Safaein M., Vlahov D., and Strathdee S.A. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV co-infected injection drug users. AIDS 19 Suppl. 3 (2005) S179-S189
22. Miles M.B., and Huberman A.M. Qualitative data analysis: An expanded sourcebook (1994), Sage, Thousand Oaks, CA
23. Mohsen A.H., Easterbrook P.J., Taylor C., Portmann B., Kulasegarem R., Murad S., et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 52 (2003) 1035-1040
24. Ogawa L.F., and Bova C. Substance use experiences and hepatitis C treatment decision-making among HIV/HCV coinfected adults. Substance Use & Misuse 44 (2009) 915-933
25. Patton M. Qualitative evaluation and research methods (1990), Sage, Thousand Oaks, CA
26. Puoti M., Bonacini M., Spinetti A., Putzolu V., Govindariajan S., Zaltron S., et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. Journal of Infectious Diseases 183 (2001) 134-137
27. Rifai M.A. Ethical impasses in the care of patients with hepatitis C. Psychosomatics 47 (2006) 540-541
28. Sandelowski M. Whatever happened to qualitative description?. Research in Nursing and Health 23 (2000) 334-340
29. Schackman B.R., Teixeira P.A., Weitzman G., Mushlin A.I., and Jacobson I.M. Quality of life tradeoffs for hepatitis C treatment: Do patients and providers agree?. Medical Decision-Making 28 (2008) 233-242
30. Selik R.M., Byers R.H., and Dworkin M.S. Trends in diseases reported in U.S. death certificates that mentioned HIV infection, 1987-1999. Journal of Acquired Immune Deficiency Syndromes 29 (2002) 378-387
31. Sherman K.E., Rouster S.D., Chung R.T., and Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US Adults AIDS Clinical Trials Group. Clinical Infectious Diseases 34 (2002) 831-837
32. Strathdee S.A., and Patterson T.L. Behavioral interventions for HIV-positive and HCV-positive drug users. AIDS and Behavior 10 (2006) 115-130
33. Sulkowski M., and Benhamou Y. Therapeutic issues in HIV/HCV-coinfected patients. Journal of Viral Hepatitis 14 (2007) 371-386
34. Sulkowski M., and Thomas D.L. Hepatitis C in the HIV-infected person. Annals of Internal Medicine 128 (2003) 197-207
35. Sulkowski M., and Thomas D.L. Epidemiology and natural history of hepatitis C virus infection in injection drug users: Implications for treatment. Clinical Infectious Diseases 40 Suppl. 5 (2005) S263-S269
36. Sulkowski M.S., Moore R.D., Mehta S.H., and Chaisson R.E. Hepatitis C and progression of HIV disease. Journal of the American Medical Association 288 (2002) 199-206
37. Sullivan-Bolyai S., Bova C., and Harper D. Developing and refining interventions in persons with health disparities: The use of qualitative description. Nursing Outlook 53 (2005) 127-133
38. Thomas D.L. Hepatitis C and human immunodeficiency virus infection. Hepatology 36 (2002) S201-S209
39. Thomas D.L. The challenge of hepatitis C in the HIV-infected person. Annual Review of Medicine 59 (2008) 473-485
40. Torriani F.J., Rodriguez-Torres M., Rockstroh J., Lissen E., Gonzalez-Garcia J., Lazzarin A., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. New England Journal of Medicine 351 (2004) 438-450
41. Weber R., Sabin C.A., Friis-Moller N., Reiss P., El-Sadr W., Kirk O., et al. Liver-related deaths in persons infected with human immunodeficiency virus. Archives of Internal Medicine 166 (2006) 1632-1641
42. Zylberger H., and Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clinical Infectious Diseases 23 (1996) 1117-1125